Mutations in p53 have been detected in up to 30 % of all breast cancer cases, and individuals with inherited p53 mutations face an elevated risk of developing ovarian, breast, pancreatic, and colorectal cancers (Lacroix et al., 2006[108]; Muller and Vousden, 2013[148]). This evidence concerns the gene TP53 and colorectal cancer.